Talin1–Piezo1–YAP Axis: Regulating Endothelial Inflammation
2026-07-05
The reference study reveals that Talin1 modulates the Piezo1–YAP signaling axis to drive inflammation in endothelial cells, highlighting its potential as a therapeutic target in atherosclerosis. By dissecting the mechanical and biochemical pathways leading to calcium influx and inflammatory gene expression, the research offers actionable insights for vascular biology and translational anti-inflammatory strategies.
Anagliptin (SK-0403): Beyond DPP-4 Inhibition in Vascular As
2026-07-04
Explore Anagliptin (SK-0403) as a potent DPP-4 inhibitor with unique vasorelaxant actions via Kv channel and SERCA pump modulation. This article delivers advanced assay insights and practical protocols for diabetes-cardiovascular interface research.
VX-745: Precision p38α MAPK Inhibitor for Inflammation Model
2026-07-03
VX-745 delivers selective, dual-action inhibition of p38α MAPK, providing researchers with a uniquely potent tool to dissect inflammatory and drug-resistance pathways. Its ability to modulate both kinase activity and dephosphorylation dynamics sets it apart for advanced cell and animal models, especially in contexts like multiple myeloma and arthritis.
Surfactant-Derived LNPs Enable Efficient mRNA Delivery to Ma
2026-07-03
This study introduces a dual-component lipid nanoparticle (LNP) system derived from quaternary ammonium surfactants for the efficient intracellular delivery of mRNA to hard-to-transfect macrophages. The findings highlight a non-PEGylated, biocompatible carrier with enhanced mRNA protection and delivery efficiency, offering new strategies for gene engineering in immune cells.
Optimizing Protease Inhibition: DiscoveryProbe™ Library in A
2026-07-02
This article provides a practical, evidence-based guide to integrating the DiscoveryProbe™ Protease Inhibitor Library (SKU L1035) into high throughput screening, apoptosis, and disease modeling workflows. Drawing on real laboratory scenarios, it contrasts common pitfalls with validated solutions, emphasizing the library’s quality, reproducibility, and ease of use for biomedical researchers.
Stat3 as a Key Mediator of Fyn Kinase-Driven Neurodegenerati
2026-07-02
This study elucidates how Stat3 signaling mediates Fyn kinase-driven dopaminergic neurodegeneration and microglial activation in a zebrafish model. The findings clarify molecular mechanisms underlying Parkinson's disease risk and highlight the importance of targeting Stat3 and NF-κB pathways for functional gene studies and therapeutic research.
Halazone and Oxidant-Induced Modulation of Sodium Channel In
2026-07-01
The reference study rigorously investigates how halazone and related oxidants modulate sodium current inactivation in voltage-clamped frog myelinated nerve fibers, challenging the traditional view of methionine’s critical role. These findings refine our understanding of sodium channel pharmacology and suggest membrane lipid modification as a key mediator, with implications for both neurophysiology and the broader use of antimicrobial sulfonamide derivatives.
M1 Macrophage Exosomal MMP8 Triggers Enteric Neuronal Injury
2026-07-01
This study uncovers how exosomes from M1 macrophages deliver MMP8 to enteric neurons, activating TGF-β signaling and promoting neuronal apoptosis. The findings clarify a key neuroimmune mechanism underlying gastrointestinal motility disorders and highlight MMP8 inhibition as a therapeutic target.
BI 2536: Potent PLK1 Inhibitor for Cell Cycle and Cancer Res
2026-06-30
BI 2536 is a highly selective ATP-competitive PLK1 inhibitor, inducing robust G2/M cell cycle arrest and apoptosis in tumor cell lines. It demonstrates nanomolar potency and complete tumor suppression in xenograft models, making it a reference compound for mechanistic and translational cancer research.
Trifluoperazine 2HCl: Dopamine D2 Inhibitor in Research
2026-06-30
Trifluoperazine 2HCl is a well-characterized dopamine D2 receptor inhibitor used to dissect dopaminergic signaling and macrophage responses. Its low nanomolar potency and high solubility enable reproducible neuropharmacology and immunology assays. This article details its mechanism, evidence base, and best practice in research protocols.
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-06-29
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide synthesis workflows. It is not suitable for in vivo or clinical applications and is intended solely for controlled in vitro protocols.
Trifluoperazine 2HCl: Advancing Host-Directed Macrophage Ass
2026-06-29
Explore how Trifluoperazine 2HCl, a potent dopamine D2 receptor inhibitor, enables innovative host-directed research into macrophage antibacterial responses. This article uniquely examines its mechanistic role in ROS and autophagy induction, offering advanced insights for assay development.
Intranasal Sumatriptan as First-Line Pediatric Migraine Ther
2026-06-28
This study demonstrates that intranasal sumatriptan, a 5-HT1 receptor agonist, is a feasible and potentially effective first-line treatment for acute pediatric migraine in the emergency department. By implementing a standardized pathway, the research identifies significant reductions in pain scores, emergency department length of stay, and associated care costs—highlighting a promising strategy for improving pediatric migraine management.
Anagliptin (SK-0403): Strategic Leverage in Vascular Diabete
2026-06-27
This thought-leadership article explores how Anagliptin (SK-0403), a potent DPP-4 inhibitor, extends its scientific and translational value beyond glycemic control by modulating vascular tone via Kv channel and SERCA pump activation. Bridging mechanistic insight with experimental and strategic guidance, the article synthesizes recent advances and outlines actionable directions for researchers investigating the intertwined challenges of diabetes and cardiovascular dysfunction. Distinct from standard product content, this piece integrates evidence-based rationale, comparative context, and future outlook for translational applications, and features APExBIO's Anagliptin as a research-standard tool.
Airway Epithelial Secretome Changes After Ozone and DEP Expo
2026-06-26
This study elucidates how acute exposure to ozone and diesel exhaust particles (DEP) disrupts airway epithelial barrier integrity and alters the cellular secretome in a physiologically relevant air–liquid interface (ALI) model. By identifying convergent activation of Wnt signaling and inflammatory cytokines, the research provides mechanistic insights into the shared pathways underlying pollutant-induced airway injury.
460 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page